Application
LY86 Antibody (C-term) (Cat. #AP14826b) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the LY86 antibody detected the LY86 protein (arrow).Application
LY86 Antibody (C-term) (Cat. #AP14826b) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the LY86 antibody detected the LY86 protein (arrow).| Product Name | LY86 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LY86; MD1; Lymphocyte antigen 86; Protein MD-1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | MD1 |
|---|---|
| Alternative Names | LY86 MD1 Lymphocyte antigen 86 Protein MD-1 |
| Molecular Weight(MW) | 17906 Da |
| Function | May cooperate with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and cytokine production. Important for efficient CD180 cell surface expression (By similarity) |
| Tissue Specificity | Highly expressed in B-cells, monocytes and tonsil |
| Cellular Localization | Secreted, extracellular space. Note=Associated with CD180 at the cell surface |
| Entrez Gene | 9450 |
|---|---|
| Nucleotide Accession | NP_004262.1 |
Application
LY86 Antibody (C-term) (Cat. #AP14826b) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the LY86 antibody detected the LY86 protein (arrow).
Application
LY86 Antibody (C-term) (Cat. #AP14826b) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the LY86 antibody detected the LY86 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
